RANI — Rani Therapeutics Holdings Share News
0.000.00%
- $15.20m
- -$29.44m
- $1.63m
U.S. RESEARCH ROUNDUP- Caseys General Stores, J M Smucker, Target
Brief: Rani Therapeutics Reports Q1 2022 Results
Rani Therapeutics Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Rani Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
Rani Therapeutics up on starting osteoporosis treatment study
Brief: Rani Therapeutics Announces Initiation Of Phase 1 Study Of Rt-102 Oral Pth
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:39 AM
U.S. STOCKS ON THE MOVE-Corning, Stride, Gatos Silver
Brief: Rani Therapeutics Appoints Lisa Rometty To Board Of Directors
Brief: Rani Therapeutics Appoints Lyn Baranowski To Board Of Directors
Brief: Rani Therapeutics Reports Second Quarter 2021 Financial Results, Provides Corporate Update
U.S. RESEARCH ROUNDUP- Immuneering, Matterport, Tenaya Therapeutics
Rani Therapeutics leaps 100% in volatile trade
NASDAQ RESUMED AT 11:22 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:17 AM
NASDAQ RESUMED AT 10:42 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:37 AM
Brief: Rani Therapeutics Holdings Inc Class A Shares Open 2.4% Above IPO Price In Nasdaq Debut
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:01 AM